ES2109682T3 - Derivados antipsicoticos de imidazoles. - Google Patents
Derivados antipsicoticos de imidazoles.Info
- Publication number
- ES2109682T3 ES2109682T3 ES94910462T ES94910462T ES2109682T3 ES 2109682 T3 ES2109682 T3 ES 2109682T3 ES 94910462 T ES94910462 T ES 94910462T ES 94910462 T ES94910462 T ES 94910462T ES 2109682 T3 ES2109682 T3 ES 2109682T3
- Authority
- ES
- Spain
- Prior art keywords
- imidazoles
- derivatives
- substituted
- dopamine
- antipsychotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000000561 anti-psychotic effect Effects 0.000 title 1
- 150000002460 imidazoles Chemical class 0.000 title 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- 102000015554 Dopamine receptor Human genes 0.000 abstract 1
- 108050004812 Dopamine receptor Proteins 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 150000001556 benzimidazoles Chemical class 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939306578A GB9306578D0 (en) | 1993-03-30 | 1993-03-30 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2109682T3 true ES2109682T3 (es) | 1998-01-16 |
Family
ID=10732977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94910462T Expired - Lifetime ES2109682T3 (es) | 1993-03-30 | 1994-03-23 | Derivados antipsicoticos de imidazoles. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5792768A (de) |
| EP (1) | EP0691960B1 (de) |
| JP (1) | JPH08508289A (de) |
| AT (1) | ATE160774T1 (de) |
| AU (1) | AU679049B2 (de) |
| CA (1) | CA2159220A1 (de) |
| DE (1) | DE69407176T2 (de) |
| ES (1) | ES2109682T3 (de) |
| GB (1) | GB9306578D0 (de) |
| WO (1) | WO1994022839A1 (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5633377A (en) * | 1990-12-28 | 1997-05-27 | Neurogen Corporation | 4-piperidino- and piperazinomethyl-2-cyclohexyl imidazole derivatives; dopamine receptor subtype specific ligands |
| GB9305644D0 (en) * | 1993-03-18 | 1993-05-05 | Merck Sharp & Dohme | Therapeutic agents |
| EP0793653A1 (de) * | 1994-11-23 | 1997-09-10 | Neurogen Corporation | Einige 4-aminomethyl-2-substituierte imidazolderivate und 2-aminomethyl - 4 - substituierte imidazolderivate; neue klassen von spezifischen liganden des dopaminrezeptorsubtyps |
| US5773616A (en) * | 1995-02-15 | 1998-06-30 | Neurogen Corporation | Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands |
| WO1996025411A1 (en) * | 1995-02-15 | 1996-08-22 | Neurogen Corporation | Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands |
| US5912246A (en) * | 1995-02-15 | 1999-06-15 | Pharmacia & Upjohn Company | Imidazo 1,2-a!pyridines for the treatment of CNS and cardiac diseases |
| US5948912A (en) * | 1995-02-15 | 1999-09-07 | Neurogen Corporation | Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands |
| US6187774B1 (en) * | 1996-03-04 | 2001-02-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and pharmaceutical applications thereof |
| DE19637237A1 (de) | 1996-09-13 | 1998-03-19 | Merck Patent Gmbh | Piperazin-Derivate |
| HUP0000189A3 (en) | 1996-11-15 | 2002-01-28 | Darwin Discovery Ltd Milton Ro | Bicyclic aryl carboxamides pharmaceutical compositions containing them and their therapeutic use |
| US6359882B1 (en) | 1997-04-01 | 2002-03-19 | Yipes Communications, Inc. | Method and apparatus for transmitting data |
| US6013654A (en) * | 1997-08-14 | 2000-01-11 | Pharmacia & Upjohn Company | Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases |
| US6166205A (en) * | 1998-09-02 | 2000-12-26 | Neurogen Corporation | 2-Aryl-4-(1-[4-heteroaryl]piperazin-1-yl)methylimidazoles: dopamine . D.sub4 receptor subtype ligands |
| CN1325397A (zh) * | 1998-09-30 | 2001-12-05 | 纽罗根公司 | 2-哌嗪烷基氨基苯并吡咯衍生物∶多巴胺受体亚型特异配体 |
| US6284759B1 (en) | 1998-09-30 | 2001-09-04 | Neurogen Corporation | 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands |
| US6107313A (en) * | 1998-10-02 | 2000-08-22 | Combichem, Inc. | Dopamine receptor antagonists |
| DE60009154D1 (de) * | 1999-12-30 | 2004-04-22 | Lundbeck & Co As H | Phenylpiperazinyl-derivate |
| IL153884A0 (en) * | 2000-07-20 | 2003-07-31 | Neurogen Corp | Capsaicin receptor ligands |
| CZ2003952A3 (cs) * | 2000-10-31 | 2003-11-12 | Basf Drucksysteme Gmbh | Použití hyperrozvětvených polyurethanů |
| US7022728B2 (en) * | 2001-03-09 | 2006-04-04 | Abbott Laboratories | Benzimidazoles that are useful in treating male sexual dysfunction |
| US20020169166A1 (en) * | 2001-03-09 | 2002-11-14 | Cowart Marlon D. | Benzimidazoles that are useful in treating sexual dysfunction |
| KR100863147B1 (ko) * | 2001-03-09 | 2008-10-13 | 아보트 러보러터리즈 | 벤즈이미다졸 및 이를 포함하는 성 기능장애 치료용 약제학적 조성물 |
| US6960589B2 (en) * | 2001-03-09 | 2005-11-01 | Abbott Laboratories | Benzimidazoles that are useful in treating sexual dysfunction |
| WO2003060475A2 (en) * | 2002-01-10 | 2003-07-24 | Neurogen Corporation | Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
| AU2003212882A1 (en) | 2002-02-01 | 2003-09-02 | Euro-Celtique S.A. | 2 - piperazine - pyridines useful for treating pain |
| US7057042B2 (en) | 2002-05-29 | 2006-06-06 | Abbott Laboratories | Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| WO2003101994A1 (en) * | 2002-05-29 | 2003-12-11 | Abbott Laboratories | Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| DE60318875T2 (de) * | 2002-06-28 | 2009-01-15 | Euro-Celtique S.A. | Therapeutische piperazin-derivate für die behandlung von schmerzen |
| US7262194B2 (en) * | 2002-07-26 | 2007-08-28 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| US20040127504A1 (en) * | 2002-09-06 | 2004-07-01 | Cowart Marlon D. | Benzimidazoles that are useful in treating sexual dysfunction |
| US7157462B2 (en) | 2002-09-24 | 2007-01-02 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| NZ555491A (en) * | 2005-01-03 | 2010-01-29 | Univ Siena | Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| US7544685B2 (en) | 2005-08-17 | 2009-06-09 | H. Lundbeck A/S | 2,3-dihydroindole compounds |
| US7946206B2 (en) * | 2007-11-21 | 2011-05-24 | Rocksmart, Llc | Quick-release system |
| US10913736B2 (en) * | 2014-08-22 | 2021-02-09 | University Of Washington | Specific inhibitors of methionyl-tRNA synthetase |
| WO2017207340A1 (de) | 2016-05-31 | 2017-12-07 | Bayer Pharma Aktiengesellschaft | Neue substituierte benzimidazole, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3362956A (en) * | 1965-08-19 | 1968-01-09 | Sterling Drug Inc | 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines |
| DK93087A (da) * | 1986-02-27 | 1987-08-28 | Duphar Int Res | Hidtil ukendte aryl substituerede (n-piperidinyl)methyl- og (n-piperazinyl)methylazoler med antipsykotiske egenskaber |
| CA2022451C (en) * | 1989-08-03 | 2001-01-23 | Albert Anthony Carr | Anti-psychotic piperidynl benzimidazole compounds |
| JPH03102485U (de) * | 1990-02-08 | 1991-10-24 | ||
| HUT71799A (en) * | 1993-03-01 | 1996-02-28 | Merck Sharp & Dohme | Pyrrolo-pyridine derivatives, pharmaceutical compositions containing the same, process for producing them |
-
1993
- 1993-03-30 GB GB939306578A patent/GB9306578D0/en active Pending
-
1994
- 1994-03-23 EP EP94910462A patent/EP0691960B1/de not_active Expired - Lifetime
- 1994-03-23 US US08/525,696 patent/US5792768A/en not_active Expired - Lifetime
- 1994-03-23 ES ES94910462T patent/ES2109682T3/es not_active Expired - Lifetime
- 1994-03-23 WO PCT/GB1994/000607 patent/WO1994022839A1/en not_active Ceased
- 1994-03-23 JP JP6521795A patent/JPH08508289A/ja active Pending
- 1994-03-23 CA CA002159220A patent/CA2159220A1/en not_active Abandoned
- 1994-03-23 AU AU62869/94A patent/AU679049B2/en not_active Ceased
- 1994-03-23 AT AT94910462T patent/ATE160774T1/de not_active IP Right Cessation
- 1994-03-23 DE DE69407176T patent/DE69407176T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08508289A (ja) | 1996-09-03 |
| EP0691960B1 (de) | 1997-12-03 |
| CA2159220A1 (en) | 1994-10-13 |
| WO1994022839A1 (en) | 1994-10-13 |
| DE69407176D1 (de) | 1998-01-15 |
| AU6286994A (en) | 1994-10-24 |
| DE69407176T2 (de) | 1998-07-02 |
| US5792768A (en) | 1998-08-11 |
| ATE160774T1 (de) | 1997-12-15 |
| AU679049B2 (en) | 1997-06-19 |
| GB9306578D0 (en) | 1993-05-26 |
| EP0691960A1 (de) | 1996-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2171768T3 (es) | Inhibidores de la resorcion osea y antagonistas de receptores de vitronectina. | |
| ATE160774T1 (de) | Antipsychotische benzimidazolderivate | |
| ES2164054T3 (es) | Antagonistas de receptores de endotelina. | |
| AR033377A1 (es) | Derivados de benzocicloalquilenilamina como antagonistas de receptores muscarinicos | |
| PT1135153E (pt) | Utilizacoes para antagonistas e agonistas de receptores eph para tratar desordens vasculares | |
| NI200900100A (es) | Antagonistas de receptor de orexina de diazepan sustituido | |
| CR20110228A (es) | Antagonistas del receptor de orexina de isonicotinamida | |
| ES2196072T3 (es) | Empleo de compuestos heterociclicos como ligandos de dopamina-d3. | |
| BR9206237A (pt) | Uso de derivados de tetrahidrocarbazole como receptores agonistas 5-HT1. | |
| ECSP067116A (es) | Antagonistas del receptor 2 de citocina quimioatrayente de sales cuaternarias | |
| BR0007595A (pt) | 4-(heterociclisulfonamido)-5-metóxi-6-(2-metoxifenó xi)-2-fenil-ou piridilpirimidinas como antagonistas de receptor de endotelina | |
| CL2007000396A1 (es) | Compuestos derivados de benzoil-piperidina, moduladores del receptor 5ht2/d3; composicion farmaceutica que los comprende;y su uso en el tratamiento y/o prevencion de patologias delsnc, tales como psicosis, esquizofrenia, depresion, ansiedad,adiccion a drogas y problemas cognitivos. | |
| MX9300842A (es) | Antagonistas de endotelina de sulfonamida. | |
| ES2138977T3 (es) | Agonistas muscarinicos. | |
| SV2008002929A (es) | Uso de un antagonista de cb1 para tratar efectos secundarios y sintomas negativos de la esquizofrenia | |
| BG99885A (en) | Pyrene-pyridine derivatives | |
| ES2058342T3 (es) | Pirroles, pirazoles y triazoles sustituidos antagonistas de la angiotensina ii. | |
| CR9088A (es) | Antagonistas del receptor 2 de citocina quimioatrayente de dipiperidina sustituida | |
| CO5011096A1 (es) | Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs | |
| ES2156934T3 (es) | Compuestos que presentan una potente actividad de antagonistas del calcio y de antioxidantes y su utilizacion como agentes citoprotectores. | |
| CL2008002911A1 (es) | Compuestos derivados de [arilo heteroarilo]-[1-piperidinilo susutituido]metanona, antagonista del receptor ccr-2, ccr-3, ccr-5; proceso de preparacion; composicion farmaceutica que los comprende; y su uso en el tratamiento de la enfermedad arterial periferica oclusiva e isquemia critica de las extremidades, entre otras. | |
| DOP2003000624A (es) | Derivados de tropano como moduladores de ccr5 | |
| ECSP066475A (es) | Derivados de tropano | |
| ATE160779T1 (de) | Antipsychotische indazolderivate | |
| MX2020012030A (es) | Lactamas funcionalizadas novedosas como moduladores del receptor 7 de 5-hidroxitriptamina y su método de uso. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 691960 Country of ref document: ES |